{
    "name": "mitomycin pyelocalyceal",
    "comment": "Rx",
    "other_names": [
        "Jelmyto"
    ],
    "classes": [
        "Antineoplastics",
        "Antibiotic"
    ],
    "source": "https://reference.medscape.com/drug/jelmyto-mitomycin-pyelocalyceal-1000343",
    "pregnancy": {
        "common": [
            "Based on animal studies and mechanism of action, can cause fetal harm",
            "Advise pregnant females of potential risk to fetus"
        ],
        "specific": [
            {
                "type": "Animal studies",
                "description": [
                    "Teratological changes observed in animal studies"
                ]
            },
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential: Use effective contraception during treatment and for 6 months after last dose",
                    "Males with female partners of reproductive potential: Use effective contraception during treatment and for 3 months after last dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Data are not available on presence in human milk, effects on breastfed children, or effects on milk production",
            "Advise women not to breastfeed during treatment and for 1 week following the last dose"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Perforation of bladder or upper urinary tract"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Ureteric obstruction, including ureteral stenosis, and hydronephrosis reported; monitor for signs and symptoms of ureteric obstruction, including flank pain, fever, and renal function changes; withhold or permanently discontinue mitomycin pyelocalyceal based on severity of ureteric obstruction",
                "May cause bone marrow suppression, particularly thrombocytopenia and neutropenia; monitor laboratory tests before each dose; withhold mitomycin pyelocalyceal for Grade 2 thrombocytopenia or neutropenia; permanently discontinue for â‰¥Grade 3",
                "Can cause fetal harm"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Anemia",
            "percent": "37"
        },
        {
            "name": "eGFR",
            "percent": "37"
        },
        {
            "name": "Increased creatinine",
            "percent": "32"
        },
        {
            "name": "Hypoalbuminemia",
            "percent": "30"
        },
        {
            "name": "Lymphopenia",
            "percent": "21"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "21"
        },
        {
            "name": "Hypocalcemia",
            "percent": "17"
        },
        {
            "name": "Hyperuricemia",
            "percent": "16"
        },
        {
            "name": "Hyperkalemia",
            "percent": "13"
        },
        {
            "name": "Hyperuricemia",
            "percent": "16"
        },
        {
            "name": "All Grades H",
            "percent": "1-10"
        },
        {
            "name": "Ureteropelvic obstruction",
            "percent": "3"
        },
        {
            "name": "Urinary tract obstruction",
            "percent": "6"
        },
        {
            "name": "Ureteric obstruction",
            "percent": "6"
        },
        {
            "name": "Obstructive uropathy",
            "percent": "2.8"
        },
        {
            "name": "eGFR",
            "percent": "1.4"
        },
        {
            "name": "Lymphopenia",
            "percent": "10"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "2.9"
        },
        {
            "name": "Hypoalbuminemia",
            "percent": "2.8"
        },
        {
            "name": "Hyperkalemia",
            "percent": "2.8"
        }
    ]
}